Algernon NeuroScience Inc
Algernon NeuroScience Inc. is a pioneering company based in Vancouver, BC, focused on investigating the potential of DMT, a natural compound, for promoting neuroplasticity and aiding recovery from stroke and traumatic brain injuries. With a dedicated team of leading experts in the field, the company is advancing its clinical research, including planned Phase 2 studies for DMT treatments.
Recognizing the significant global market for stroke and TBI treatments, Algernon aims to contribute to groundbreaking brain recovery research. The company is committed to innovation and discovery in the realm of neurotherapeutics, positioning itself at the forefront of this critical area of medical science.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
